Division of Fresenius SE & Co. KGaA
Latest From Xenios AG
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in October 2016.
- Surgical Equipment & Devices
- Therapeutic Areas
- Respiratory, Pulmonary
- Western Europe
- Parent & Subsidiaries
- Fresenius SE & Co. KGaA
- Senior Management
Georg Matheis, MD, PhD, Managing Dir.
Jürgen Böhm, MD, Managing Dir., Chief Mktg. Officer & CMO
Knut Jöchle, PhD, VP, R&D
Michael Hinsberger-Musiol, VP, Sales & Mktg.
Heiko Maier, VP, Fin.
- Contact Info
Phone: 7131 2706 0
Im Zukunftspark 1
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.